Target intelligence / Profile preview

Forkhead box protein I1 (FOXI1)

Target
FOXI1
Molecular classification
Transcription factor, Forkhead box family
01

Overview

Forkhead box protein I1 (FOXI1) is a member of the forkhead box (FOX) transcription factor family, characterized by a conserved forkhead DNA-binding domain. FOXI1 plays crucial roles in the development, differentiation, and function of multiple epithelial tissues, primarily by regulating the expression of genes involved in ion transport and homeostasis, such as vacuolar H⁺-ATPase subunits and SLC26A4 (pendrin). It is essential for proper cochlear, vestibular, renal, and epididymal function, and its absence or dysfunction leads to sensorineural hearing loss, balance deficits, and developmental abnormalities, such as Pendred syndrome and enlarged vestibular aqueduct. FOXI1 is also implicated in modulating chromatin structure, remaining bound to condensed chromosomes during mitosis and influencing gene accessibility. In cancer, FOXI1 shows tumor suppressive activity by activating specific signaling pathways in gastric cancer and serves as a diagnostic marker to distinguish renal tumor subtypes. No drugs are currently known to directly modify FOXI1 activity, and most clinical or pathological relevance is associated with its function or expression levels.

Other names
FKHL10FREAC6FREAC-6HFH-3HNF-3/fork-head homolog 3FKH10HFH3forkhead box protein I1HNF-3/fork-head homolog-3forkhead-like 10forkhead-related activator 6forkhead-related protein FKHL10forkhead-related transcription factor 6hepatocyte nuclear factor 3 forkhead homolog 3
02

Biological functions

Regulation of epithelial developmentChromatin remodelingTranscriptional activation of ion transport genes (e.g., SLC26A4, Vacuolar H⁺-ATPase subunits)EmbryogenesisIon homeostasis (auditory, renal, reproductive systems)
03

Disease associations

Deafness, autosomal recessive 4Pendred syndromeEnlarged vestibular aqueductOncological context (diagnostic distinction in renal tumors, tumor suppression in gastric cancer)
04

Safety considerations

Knockout/mutation leads to inner ear and kidney malformations and hearing loss, indicating biological risks of loss-of-function.
05

Biomarkers

FOXI1 expression (diagnostic distinction in low-grade renal oncocytic tumors)FOXI1 gene mutations (associated with Pendred syndrome and enlarged vestibular aqueduct)

Beyond the preview

Go deeper on Forkhead box protein I1 (FOXI1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Forkhead box protein I1 (FOXI1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call